Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 May 5:8:511.
doi: 10.3389/fimmu.2017.00511. eCollection 2017.

Toll-Interacting Protein in Resolving and Non-Resolving Inflammation

Affiliations
Review

Toll-Interacting Protein in Resolving and Non-Resolving Inflammation

Elizabeth J A Kowalski et al. Front Immunol. .

Abstract

Innate leukocytes manifest dynamic and distinct inflammatory responses upon challenges with rising dosages of pathogen-associated molecular pattern molecules such as lipopolysaccharide (LPS). To differentiate signal strengths, innate leukocytes may utilize distinct intracellular signaling circuitries modulated by adaptor molecules. Toll-interacting protein (Tollip) is one of the critical adaptor molecules potentially playing key roles in modulating the dynamic adaptation of innate leukocytes to varying dosages of external stimulants. While Tollip may serve as a negative regulator of nuclear factor κ of activated B cells signaling pathway in cells challenged with higher dosages of LPS, it acts as a positive regulator for low-grade chronic inflammation in leukocytes programmed by subclinical low-dosages of LPS. This review aims to discuss recent progress in our understanding of complex innate leukocyte dynamics and its relevance in the pathogenesis of resolving versus non-resolving chronic inflammatory diseases.

Keywords: lipopolysaccharide; low-grade inflammation; lysosome fusion; mitochondria; toll-interacting protein; toll-like receptor 4.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Illustration of distinct domains of toll-interacting protein, relevant binding partners, and potential functions.
Figure 2
Figure 2
Potential roles and modulations of toll-interacting protein (Tollip) in acute and chronic inflammation. Under strong and acute inflammatory conditions, cell membrane-localized Tollip serves as a negative inhibitor for nuclear factor κ of activated B cells (NFκB) signaling pathway, facilitates the resolution of inflammation, and clearance of cellular debris as well as excessive lipids. However, under low-grade inflammatory conditions, Tollip undergoes translocation from cellular membrane to mitochondria. Dislocated Tollip loses its homeostatic function, fails to facilitate lysosome fusion. Instead, mitochondrial Tollip may facilitate non-resolving low-grade inflammation.

Similar articles

Cited by

References

    1. Medzhitov R, Janeway C., Jr Innate immune recognition: mechanisms and pathways. Immunol Rev (2000) 173:89–97. 10.1034/j.1600-065X.2000.917309.x - DOI - PubMed
    1. Akira S, Takeda K. Toll-like receptor signalling. Nat Rev Immunol (2004) 4(7):499–511. 10.1038/nri1391 - DOI - PubMed
    1. Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell (2006) 124(4):783–801. 10.1016/j.cell.2006.02.015 - DOI - PubMed
    1. Alexopoulou L, Holt AC, Medzhitov R, Flavell RA. Recognition of double-stranded RNA and activation of NF-kappaB by toll-like receptor 3. Nature (2001) 413(6857):732–8. 10.1038/35099560 - DOI - PubMed
    1. Diebold SS, Kaisho T, Hemmi H, Akira S, Reis e Sousa C. Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science (2004) 303(5663):1529–31. 10.1126/science.1093616 - DOI - PubMed

LinkOut - more resources